Mishra A, Durgapal H, Manivel V, Acharya S K, Rao K V, Panda S K
Department of Pathology, All India Institute of Medical Sciences, New Delhi.
Clin Exp Immunol. 1992 Nov;90(2):194-8.
Antibody responses of patients with acute (n = 73), fulminant (n = 30) and chronic (n = 51) hepatitis B virus (HBV) infection as well as recovered individuals (n = 7) were studied against three synthetic peptides, Pre-S1 amino acids (aa. 12-32), Pre-S2 amino acids (aa. 120-145), and S amino acids (aa. 124-147) of the envelope region (HBsAg). T cell blastogenic response was investigated in a proportion of the patients (27 acute, nine fulminant, 13 chronic hepatitis and seven recovered individuals) along with seven HBV vaccinated and three normal individuals. The presence of T cell response against S peptide was observed in all the cases (9/9, 100%) during early acute hepatitis. This was suppressed during late stages (8/18, 44%) followed by partial reversal during recovery (5/7, 71%). T cell response and antibodies to Pre-S1 and Pre-S2 peptides were present only in one-third of the patients throughout these periods. The T cell blastogenic response as well as antibody reactivity against these peptides were absent and minimal in chronic hepatitis. Immune response against envelope protein appears to play a major role in acute hepatic injury due to HBV infection and help in virus clearance.
研究了急性(n = 73)、暴发性(n = 30)和慢性(n = 51)乙型肝炎病毒(HBV)感染患者以及康复个体(n = 7)针对三种合成肽的抗体反应,这三种合成肽分别为包膜区(HBsAg)的前S1氨基酸(aa. 12 - 32)、前S2氨基酸(aa. 120 - 145)和S氨基酸(aa. 124 - 147)。在部分患者(27例急性、9例暴发性、13例慢性肝炎患者和7例康复个体)以及7例接种HBV疫苗者和3例正常个体中研究了T细胞增殖反应。在急性肝炎早期,所有病例(9/9,100%)均观察到针对S肽的T细胞反应。在后期该反应受到抑制(8/18,44%),随后在恢复过程中部分逆转(5/7,71%)。在整个这些时期,仅三分之一的患者存在针对前S1和前S2肽的T细胞反应和抗体。在慢性肝炎中,针对这些肽的T细胞增殖反应以及抗体反应不存在或非常微弱。针对包膜蛋白的免疫反应似乎在HBV感染所致急性肝损伤中起主要作用,并有助于病毒清除。